JAMA Intern Med:患者生命体征实时预测工具用于识别病情稳定患者

2021-12-29 MedSci原创 MedSci原创

住院患者生命体征实时预测工具可以帮助医生识别临床状态稳定患者,减少不必要查房,提高患者睡眠质量

住院患者失眠是一种常见疾病,即使是短期睡眠不足也会损害记忆和学习能力,短期睡眠不足已被证明会降低胰岛素敏感性,增加血压。在重症监护病房(ICU)使用耳塞和其他非药物性睡眠辅助设备可改善睡眠,减少谵妄风险。住院患者经常经历医源性睡眠中断,近日研究人员考察了一种临床决策支持工具,对识别临床稳定患者,减少夜间生命体征检查的效果。


本次随机临床试验中,住院患者随机1:1接受干预或常规治疗。参与者在一个三级护理学术医疗中心接受一般医疗服务(不在重症监护病房),共1699名患者。干预组实时将患者数据输入逻辑回归模型,若模型计算认为患者夜间生命体征稳定的可能性高,则告知医生取消1小时后或当夜的查房。研究的主要结果是谵妄,次要结果包括平均夜间生命体征检查次数,转入ICU或Code Blue(呼叫急救)。
1699名住院患者参与研究,男性566名,平均年龄53岁。与对照组相比,干预组夜间生命体征检查的平均次数显著减少(0.97 vs1.41次),且转入ICU(49[5%] vs47[5%])或呼叫急救(2[0.2%]vs9[0.9%])率无显著变化。组间谵妄率无显著差异 (108 [11%] vs 123 [13%])。


研究认为,住院患者生命体征实时预测工具可以帮助医生识别临床状态稳定患者,减少不必要查房,提高患者睡眠质量。
原始出处:
Nader Najafi et al. Effectiveness of an Analytics-Based Intervention for Reducing Sleep Interruption in Hospitalized Patients A Randomized Clinical Trial. JAMA Intern Med,December 28,2021。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1765167, encodeId=6cc01e651672c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Aug 08 13:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803399, encodeId=833c180339969, content=<a href='/topic/show?id=3a91e530979' target=_blank style='color:#2F92EE;'>#稳定患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75309, encryptionId=3a91e530979, topicName=稳定患者)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/6F20312C71B4B22F603078C6DCFA72CE/100, createdBy=d3572500071, createdName=ms306040998833292, createdTime=Wed Jun 22 01:43:20 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799566, encodeId=07191e99566df, content=<a href='/topic/show?id=f9b1e08715e' target=_blank style='color:#2F92EE;'>#病情稳定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70871, encryptionId=f9b1e08715e, topicName=病情稳定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Thu Jul 07 02:43:20 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745918, encodeId=a2db1e45918c4, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Fri Aug 05 00:43:20 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611386, encodeId=bd3d1611386f7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Dec 31 10:43:20 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085552, encodeId=b15c108555262, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Dec 29 20:34:58 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1765167, encodeId=6cc01e651672c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Aug 08 13:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803399, encodeId=833c180339969, content=<a href='/topic/show?id=3a91e530979' target=_blank style='color:#2F92EE;'>#稳定患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75309, encryptionId=3a91e530979, topicName=稳定患者)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/6F20312C71B4B22F603078C6DCFA72CE/100, createdBy=d3572500071, createdName=ms306040998833292, createdTime=Wed Jun 22 01:43:20 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799566, encodeId=07191e99566df, content=<a href='/topic/show?id=f9b1e08715e' target=_blank style='color:#2F92EE;'>#病情稳定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70871, encryptionId=f9b1e08715e, topicName=病情稳定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Thu Jul 07 02:43:20 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745918, encodeId=a2db1e45918c4, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Fri Aug 05 00:43:20 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611386, encodeId=bd3d1611386f7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Dec 31 10:43:20 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085552, encodeId=b15c108555262, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Dec 29 20:34:58 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1765167, encodeId=6cc01e651672c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Aug 08 13:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803399, encodeId=833c180339969, content=<a href='/topic/show?id=3a91e530979' target=_blank style='color:#2F92EE;'>#稳定患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75309, encryptionId=3a91e530979, topicName=稳定患者)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/6F20312C71B4B22F603078C6DCFA72CE/100, createdBy=d3572500071, createdName=ms306040998833292, createdTime=Wed Jun 22 01:43:20 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799566, encodeId=07191e99566df, content=<a href='/topic/show?id=f9b1e08715e' target=_blank style='color:#2F92EE;'>#病情稳定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70871, encryptionId=f9b1e08715e, topicName=病情稳定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Thu Jul 07 02:43:20 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745918, encodeId=a2db1e45918c4, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Fri Aug 05 00:43:20 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611386, encodeId=bd3d1611386f7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Dec 31 10:43:20 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085552, encodeId=b15c108555262, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Dec 29 20:34:58 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1765167, encodeId=6cc01e651672c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Aug 08 13:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803399, encodeId=833c180339969, content=<a href='/topic/show?id=3a91e530979' target=_blank style='color:#2F92EE;'>#稳定患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75309, encryptionId=3a91e530979, topicName=稳定患者)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/6F20312C71B4B22F603078C6DCFA72CE/100, createdBy=d3572500071, createdName=ms306040998833292, createdTime=Wed Jun 22 01:43:20 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799566, encodeId=07191e99566df, content=<a href='/topic/show?id=f9b1e08715e' target=_blank style='color:#2F92EE;'>#病情稳定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70871, encryptionId=f9b1e08715e, topicName=病情稳定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Thu Jul 07 02:43:20 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745918, encodeId=a2db1e45918c4, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Fri Aug 05 00:43:20 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611386, encodeId=bd3d1611386f7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Dec 31 10:43:20 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085552, encodeId=b15c108555262, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Dec 29 20:34:58 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1765167, encodeId=6cc01e651672c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Aug 08 13:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803399, encodeId=833c180339969, content=<a href='/topic/show?id=3a91e530979' target=_blank style='color:#2F92EE;'>#稳定患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75309, encryptionId=3a91e530979, topicName=稳定患者)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/6F20312C71B4B22F603078C6DCFA72CE/100, createdBy=d3572500071, createdName=ms306040998833292, createdTime=Wed Jun 22 01:43:20 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799566, encodeId=07191e99566df, content=<a href='/topic/show?id=f9b1e08715e' target=_blank style='color:#2F92EE;'>#病情稳定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70871, encryptionId=f9b1e08715e, topicName=病情稳定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Thu Jul 07 02:43:20 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745918, encodeId=a2db1e45918c4, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Fri Aug 05 00:43:20 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611386, encodeId=bd3d1611386f7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Dec 31 10:43:20 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085552, encodeId=b15c108555262, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Dec 29 20:34:58 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1765167, encodeId=6cc01e651672c, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Mon Aug 08 13:43:20 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803399, encodeId=833c180339969, content=<a href='/topic/show?id=3a91e530979' target=_blank style='color:#2F92EE;'>#稳定患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75309, encryptionId=3a91e530979, topicName=稳定患者)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/6F20312C71B4B22F603078C6DCFA72CE/100, createdBy=d3572500071, createdName=ms306040998833292, createdTime=Wed Jun 22 01:43:20 CST 2022, time=2022-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799566, encodeId=07191e99566df, content=<a href='/topic/show?id=f9b1e08715e' target=_blank style='color:#2F92EE;'>#病情稳定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70871, encryptionId=f9b1e08715e, topicName=病情稳定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Thu Jul 07 02:43:20 CST 2022, time=2022-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745918, encodeId=a2db1e45918c4, content=<a href='/topic/show?id=5de66892039' target=_blank style='color:#2F92EE;'>#生命体征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68920, encryptionId=5de66892039, topicName=生命体征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e735624029, createdName=lxg963, createdTime=Fri Aug 05 00:43:20 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611386, encodeId=bd3d1611386f7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Dec 31 10:43:20 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085552, encodeId=b15c108555262, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Wed Dec 29 20:34:58 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 仁术2021

    不错,学习了。

    0

相关资讯

PLOS ONE:熬完夜补觉有用吗?别妄想了!欠的觉,你还不了!

长期睡眠不足会损害受试者的各种能力,且并不能靠短期补觉来进行弥补。

JAMA子刊:注意了,睡得太多睡得太少都与抑郁和老年痴呆都有关!

睡眠障碍在老龄人中很常见,并与认知能力有关。

PSYCHOL MED :正念疗法可能有助于改善失眠

以正念为基础的疗法作为一种可行的失眠症治疗方法,为无法获得标准一线疗法的人提供了有效选择。

Neurology: 20万大数据研究: 脑外伤后,多数人的长期睡眠质量堪忧

20万大数据研究 脑外伤后,多数人的长期睡眠质量堪忧

ANB:熬完夜补觉有用吗?别妄想了!欠3天的觉,你就身心俱损了!

连续的睡眠损失与日常情感和身体健康的退化轨迹有关。

脆弱的男性?JAMA子刊:男性缺觉死亡风险更高!男性的'脆弱'不止体现在这.....

现代人,不论男女,都对熬夜修仙有着迷之执念:白天是枯燥的、乏味的,莫得灵魂,属于咸鱼;晚上才是人生的B面——一个人静静地看小说、打游戏、逛某宝、写方案